Assiut University: Eclampsia trials
The registry lists 17 Eclampsia studies with Assiut University as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 2Phase 3 2Phase 4 2No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Role of Vaspin in Pathophysiology of Pre-eclampsiaNot yet recruitingNCT06437535
- Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia.Not yet recruitingNCT06385600Not applicable
- co Ihibtory Receptor in PreeclampsiaNot yet recruitingNCT05294952Phase 4
- State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis AssaysStatus unknownNCT05625763
- Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic WomenStatus unknownNCT05622838
- Body Fat Index for Obstetric Risk StratificationStatus unknownNCT05533996Not applicable
- Improved Characterisation of EclampsiaStatus unknownNCT05199558
- Dexamedtomidine in Control of Intracranial Pressure in PreeclampsiaStatus unknownNCT05119101Phase 1
- Cardiovascular Changes in Infants of Preeclampsia MotherStatus unknownNCT04699825Not applicable
- Role and Expression of MXRA5 in Placental Connective Tissue Remodelling in PreeclampsiaStatus unknownNCT04287998
- Impact of Body Mass Index on Serum Maternal and Fetal Magnesium LevelStatus unknownNCT03928691
- Peri-operative Dexmedetomidine Infusion in Pre-eclamptic PatientsCompletedNCT03391609Phase 2/3
- Predictors of Intrauterine Growth RestrictionStatus unknownNCT03349671
- Use of Sildenafil Citrate in Management of Mild Pre-eclampsiaStatus unknownNCT03262961Phase 2/3
- Diagnostic Value of MicroRNA 210 In PreeclampsiaStatus unknownNCT03193554
- Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsiaCompletedNCT03164304Phase 4
- Pre-eclampsia and Biochemical MarkersCompletedNCT02665897